AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

A Phase 1, Single-Center, Randomized, Placebo-Controlled, Ascending Single-Dose Study of the Pharmacokinetics, Safety, and Tolerability of Oral XG005 in Healthy Volunteers

Phase 1

Completed

Conditions: Chronic Pain

Registration Number: ACTRN12617001330336

Lead Sponsor: Xgene Pharmaceutical Inc.

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method

Secondary Outcome Measures

Name	Time	Method

Related Trials

A Phase 1 Single-Center, Randomized, Placebo-Controlled, Double-Blind Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Candidate Topical Antimicrobial (NEO101) in the Reduction of Propionibacterium acnes among Healthy Young Adult Me

CompletedPhase 1

eosil, Inc.

Updated 1/13/2020

A phase 1, randomized, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetic profiles of OLX10010 in healthy subjects compared to placebo

CompletedPhase 1

OliX Pharmaceuticals, Inc.

Updated 9/2/2019

A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700

Completed

Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)

Updated 4/23/2024

A Phase 1 Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects

CompletedPhase 1

Glyscend Pty Ltd

Updated 1/9/2023

Phase I, Single-Center, Randomized, Placebo-Controlled, Double-Blinded Study with Single Ascending Doses, Evaluating the Safety and Tolerability of T20K, Administered by a 1-hr IV Infusion in Healthy Male Volunteers

Completed

Cyxone AB

Updated 4/15/2024

A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

Phase 1

Wakayama Naohiko

Updated 4/1/2024

A phase 1, Randomised, placebo-controlled, single-blind, single-ascending dose study, to determine the safety and tolerability of intravenous Gemini in healthy volunteers.

Phase 1

Revelation Biosciences Sub Inc

Updated 2/19/2024

Safety and tolerability of single and multiple-ascending doses of the study drug ACP-014 in Healthy volunteers.

CompletedPhase 1

Ascendis Pharma Bone Diseases A/S

Updated 9/10/2018

A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Single-Dose or Open-Label Multiple-Dose Study of KHK4083 in Healthy Adults and Subjects with Ulcerative Colitis

Phase 1

Kyowa Hakko Kirin Co., Ltd.

Updated 10/17/2023

Study of effects of AUT00206 in healthy males - ketamine challenge

Phase 1

Autifony Therapeutics Limited

Updated 8/8/2016

Home Terms & Conditions Privacy Policy

AI-Powered Research

Premium Access

A Phase 1, Single-Center, Randomized, Placebo-Controlled, Ascending Single-Dose Study of the Pharmacokinetics, Safety, and Tolerability of Oral XG005 in Healthy Volunteers

Recruitment & Eligibility

Study & Design

Related Research Topics

Related Trials

A Phase 1 Single-Center, Randomized, Placebo-Controlled, Double-Blind Pilot Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Candidate Topical Antimicrobial (NEO101) in the Reduction of Propionibacterium acnes among Healthy Young Adult Me

A phase 1, randomized, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetic profiles of OLX10010 in healthy subjects compared to placebo

A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700

A Phase 1 Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects

Phase I, Single-Center, Randomized, Placebo-Controlled, Double-Blinded Study with Single Ascending Doses, Evaluating the Safety and Tolerability of T20K, Administered by a 1-hr IV Infusion in Healthy Male Volunteers

A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

A phase 1, Randomised, placebo-controlled, single-blind, single-ascending dose study, to determine the safety and tolerability of intravenous Gemini in healthy volunteers.

Safety and tolerability of single and multiple-ascending doses of the study drug ACP-014 in Healthy volunteers.

A Phase 1, Single-Blind, Randomized, Placebo-Controlled, Single-Dose or Open-Label Multiple-Dose Study of KHK4083 in Healthy Adults and Subjects with Ulcerative Colitis

Study of effects of AUT00206 in healthy males - ketamine challenge

Clinical Trial Alerts